rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2008-4-7
|
pubmed:abstractText |
Cases of severe unexplained liver disease in HIV-infected individuals have recently been reported and are often associated with exposure to didanosine (ddl) and nodular regenerative hyperplasia. Herein, we examine the clinical outcome following ddl removal.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1359-6535
|
pubmed:author |
pubmed-author:AlbertosSoniaS,
pubmed-author:BabudieriSergioS,
pubmed-author:BarreiroPabloP,
pubmed-author:Garcia-GascoPilarP,
pubmed-author:Garcia-SamaniegoJavierJ,
pubmed-author:MaidaIvanaI,
pubmed-author:Martin-CarboneroLuzL,
pubmed-author:MuraMaría StellaMS,
pubmed-author:RiosMaría JoséMJ,
pubmed-author:SorianoVincentV,
pubmed-author:SotgiuGiovanniG,
pubmed-author:VispoMaría EugeniaME
|
pubmed:issnType |
Print
|
pubmed:volume |
13
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
103-7
|
pubmed:meshHeading |
pubmed-meshheading:18389904-Adult,
pubmed-meshheading:18389904-Anti-HIV Agents,
pubmed-meshheading:18389904-Female,
pubmed-meshheading:18389904-HIV Infections,
pubmed-meshheading:18389904-Humans,
pubmed-meshheading:18389904-Hypertension, Portal,
pubmed-meshheading:18389904-Liver,
pubmed-meshheading:18389904-Male,
pubmed-meshheading:18389904-Prevalence,
pubmed-meshheading:18389904-Treatment Outcome
|
pubmed:year |
2008
|
pubmed:articleTitle |
Antiretroviral-associated portal hypertension: a new clinical condition? Prevalence, predictors and outcome.
|
pubmed:affiliation |
Department of Infectious Diseases, Hospital Carlos III, Madrid. Spain.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|